Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for CYTK

Show aggregate CYTK holdings

News associated with CYTK

Cytokinetics Upsizes Convertible Notes Offering To $650 Mln

(RTTNews) - Cytokinetics Inc. (CYTK) announced the pricing of its offering of $650.0 million aggregate principal amount of 1.75% convertible senior notes due 2031 in a private placement. The aggregate principal amount of the offering was increased from the previously announced of - 2025-09-17 02:15:35

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives $75.38 Average Target Price from Brokerages

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-09-12 02:48:52

Barclays Raises Cytokinetics (NASDAQ:CYTK) Price Target to $71.00

Cytokinetics (NASDAQ:CYTK – Get Free Report) had its price objective upped by investment analysts at Barclays from $53.00 to $71.00 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 42.71% from the […] - 2025-09-05 05:11:01

Cytokinetics (NASDAQ:CYTK) Earns Buy Rating from Needham & Company LLC

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. They presently have a $72.00 price objective on the biopharmaceutical company’s stock. Needham & Company LLC’s target price suggests a potential upside of 44.03% from the […] - 2025-09-04 04:34:50

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 14:33:33

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 13:44:52

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:52:53

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:27:04

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 10:14:11

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 08:10:07

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 06:59:07

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 05:15:06

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 04:43:16

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 03:40:04

Stocks Retreat as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 01:21:35

Stocks Tumble on Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 20:15:06

Stocks Under Pressure from Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 17:45:25

Tuesday's ETF Movers: XBI, REMX

In trading on Tuesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Mineralys Therapeutics, up about 87% and shares of Cytokinetics, up about 40.7% on the day. And under - 2025-09-02 15:05:25

Stocks Under Pressure from Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 13:49:14

Stocks Tumble on Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 13:32:33

Stocks Tumble on Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 12:50:37

Thursday's ETF with Unusual Volume: TCAL

The T Rowe Price Capital Appreciation Premium Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 157,000 shares traded versus three month average volume of about 54,000. Shares of TCAL were down about 0.3% on the day. Components of that ETF wit - 2025-08-21 13:31:24

Vanguard Group Inc. Sells 66,274 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)

Vanguard Group Inc. decreased its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 0.6% in the 1st quarter, HoldingsChannel reports. The fund owned 11,849,547 shares of the biopharmaceutical company’s stock after selling 66,274 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Cytokinetics worth $476,233,000 as of its most recent filing with […] - 2025-08-15 05:04:48

Wall Street Zen Upgrades Cytokinetics (NASDAQ:CYTK) to “Hold”

Cytokinetics (NASDAQ:CYTK – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “hold” rating in a research note issued to investors on Sunday. CYTK has been the topic of a number of other research reports. HC Wainwright reaffirmed a “buy” rating and issued a […] - 2025-08-12 02:18:50

XTX Topco Ltd Cuts Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)

XTX Topco Ltd trimmed its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 23.8% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,357 shares of the biopharmaceutical company’s stock after selling 2,293 shares during the period. XTX Topco Ltd’s holdings in Cytokinetics were worth $296,000 at the end of the […] - 2025-08-11 05:44:57

Citigroup Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $77.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Citigroup from $80.00 to $77.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on CYTK. Bank of America reduced their target […] - 2025-08-11 05:06:52

KLP Kapitalforvaltning AS Acquires 600 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)

KLP Kapitalforvaltning AS raised its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 2.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,600 shares of the biopharmaceutical company’s stock after acquiring an additional 600 shares during the quarter. KLP Kapitalforvaltning AS’s […] - 2025-07-29 06:16:49

Edgestream Partners L.P. Makes New $732,000 Investment in Cytokinetics, Incorporated (NASDAQ:CYTK)

Edgestream Partners L.P. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 18,216 shares of the biopharmaceutical company’s stock, valued at approximately $732,000. Other hedge funds and other institutional investors have […] - 2025-07-20 05:25:05

Principal Financial Group Inc. Purchases 358,778 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)

Principal Financial Group Inc. grew its stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 132.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 629,911 shares of the biopharmaceutical company’s stock after buying an additional 358,778 […] - 2025-07-09 05:45:06

Noteworthy Thursday Option Activity: CYTK, GOOG, HOFT

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cytokinetics Inc (Symbol: CYTK), where a total of 7,451 contracts have traded so far, representing approximately 745,100 underlying shares. That amounts to about 46.8% o - 2025-06-12 18:17:36

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CYTK holdings

Date	Number of CYTK Shares Held	Base Market Value of CYTK Shares	Local Market Value of CYTK Shares	Change in CYTK Shares Held	Change in CYTK Base Value	Current Price per CYTK Share Held	Previous Price per CYTK Share Held
2025-09-26 (Friday)	76,154	USD 3,838,162	USD 3,838,162
2025-09-25 (Thursday)	76,154	USD 3,642,446	USD 3,642,446	0	USD -35,031	USD 47.83	USD 48.29
2025-09-24 (Wednesday)	76,154	USD 3,677,477	USD 3,677,477
2025-09-17 (Wednesday)	75,660	USD 3,598,390	USD 3,598,390	0	USD -166,452	USD 47.56	USD 49.76
2025-09-16 (Tuesday)	75,660	USD 3,764,842	USD 3,764,842
2025-09-12 (Friday)	75,166	USD 3,843,238	USD 3,843,238
2025-09-11 (Thursday)	75,166	USD 4,007,851	USD 4,007,851

Share Trades of CYTK by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-08-21	SELL	-238			38.050*		41.58 Profit of 9,895 on sale
2025-07-31	BUY	711			37.640*		41.63
2025-07-28	SELL	-237			36.630*		41.73 Profit of 9,889 on sale
2025-06-30	SELL	-474			33.040*		42.38 Profit of 20,088 on sale
2025-06-25	SELL	-237			33.110*		42.57 Profit of 10,089 on sale
2025-06-20	SELL	-474			32.430*		42.78 Profit of 20,276 on sale
2025-05-30	BUY	9,029			31.020*		43.98
2025-05-23	BUY	207			30.540*		44.54
2025-05-19	SELL	-207			30.750*		44.99 Profit of 9,313 on sale
2025-05-15	SELL	-621			29.840*		45.25 Profit of 28,099 on sale
2025-05-12	SELL	-207			32.130*		45.64 Profit of 9,447 on sale
2025-05-09	SELL	-207			31.695*		45.76 Profit of 9,473 on sale
2025-04-30	SELL	-207			42.840*		46.36 Profit of 9,596 on sale
2025-04-24	SELL	-414			40.330*		46.58 Profit of 19,284 on sale
2025-04-17	SELL	-207			39.480*		47.01 Profit of 9,730 on sale
2025-04-15	SELL	-621			38.560*		47.18 Profit of 29,301 on sale
2025-04-14	SELL	-621			39.810*		47.27 Profit of 29,352 on sale
2025-04-09	SELL	-828			37.320*		47.58 Profit of 39,399 on sale
2025-04-07	SELL	-1,456			35.990*		47.87 Profit of 69,697 on sale
2025-04-04	SELL	-2,080			37.360*		47.99 Profit of 99,825 on sale
2025-03-31	BUY	208			40.190*		48.31
2025-03-19	SELL	-416			43.450*		48.76 Profit of 20,286 on sale
2025-03-14	SELL	-1,248			44.360*		48.96 Profit of 61,099 on sale
2025-03-13	SELL	-418			44.400*		49.02 Profit of 20,491 on sale
2025-03-12	SELL	-7,106			43.990*		49.10 Profit of 348,872 on sale
2025-03-07	SELL	-418			43.430*		49.34 Profit of 20,624 on sale
2025-03-06	SELL	-627			43.270*		49.43 Profit of 30,995 on sale
2025-03-03	SELL	-209			42.890*		49.72 Profit of 10,392 on sale
2025-02-28	BUY	1,369			46.000*		49.78
2025-02-26	SELL	-201			46.860*		49.87 Profit of 10,024 on sale
2025-02-25	SELL	-603			46.650*		49.93 Profit of 30,106 on sale
2025-02-18	BUY	1,005			45.390*		50.08
2025-02-13	BUY	201			41.620*		50.41
2025-02-12	BUY	201			42.180*		50.58
2025-02-11	BUY	603			41.560*		50.77
2025-02-06	BUY	1,809			46.170*		51.24
2025-01-27	BUY	201			49.940*		51.64
2024-12-30	BUY	1,005			47.150*		52.00
2024-12-06	BUY	804			50.960*		52.14
2024-12-05	BUY	201			50.400*		52.20
2024-12-04	BUY	1,005			50.440*		52.26
2024-11-29	BUY	1,000			51.860*		52.37
2024-11-27	BUY	800			52.220*		52.38
2024-11-26	BUY	200			52.020*		52.40
2024-11-25	BUY	2,803			50.250*		52.50
2024-11-21	BUY	960			47.670*		52.94
2024-11-20	BUY	576			49.860*		53.11
2024-11-18	BUY	2,304			51.940*		53.31
2024-11-12	BUY	1,536			56.190*		53.12
2024-11-08	BUY	960			57.980*		52.77
2024-11-07	BUY	2,865			55.840*		52.53
2024-11-06	BUY	382			55.500*		52.28
2024-10-31	BUY	191			51.000*		52.57

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CYTK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer